Loomis, Sayles & Company’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.97M | Buy |
337,137
+149,766
| +80% | +$4.43M | 0.01% | 381 |
|
|
2025
Q1 | $5.59M | Buy |
187,371
+187,262
| +171,800% | +$5.59M | 0.01% | 414 |
|
|
2024
Q4 | $3K | Sell |
109
-18,966
| -99% | -$522K | ﹤0.01% | 715 |
|
|
2024
Q3 | $737K | Sell |
19,075
-182,234
| -91% | -$7.04M | ﹤0.01% | 467 |
|
|
2024
Q2 | $6.48M | Sell |
201,309
-70,643
| -26% | -$2.27M | 0.01% | 406 |
|
|
2024
Q1 | $10.6M | Sell |
271,952
-4,177
| -2% | -$162K | 0.02% | 349 |
|
|
2023
Q4 | $8.5M | Buy |
276,129
+2,501
| +0.9% | +$77K | 0.01% | 352 |
|
|
2023
Q3 | $6.12M | Buy |
273,628
+67,439
| +33% | +$1.51M | 0.01% | 378 |
|
|
2023
Q2 | $4.43M | Buy |
+206,189
| New | +$4.43M | 0.01% | 403 |
|